The purpose of this study is to investigate solid tumors. This study investigates the safety and tolerability of an investigational medication in people with advanced solid tumors.
This study evaluates how the investigational medication works in the body and its potential effects on tumors. It will help determine the right dose and check if the side effects are manageable.
- Who can participate: Adults aged 18 and older with advanced solid tumors can participate. Participants should have no available alternative treatments, meet ECOG performance status criteria, and have measurable lesions.
- Study details: Participants will take the investigational medication by mouth once a day. They will be closely monitored by doctors.